Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
Publication
, Journal Article
Haynes, BF; Yasutomi, Y; Torres, JV; Gardner, MB; Langlios, AJ; Bolognesi, DP; Matthews, TJ; Scearce, RM; Jones, DM; Moody, MA
Published in: Trans Assoc Am Physicians
1993
Duke Scholars
Published In
Trans Assoc Am Physicians
ISSN
0066-9458
Publication Date
1993
Volume
106
Start / End Page
33 / 41
Location
United States
Related Subject Headings
- T-Lymphocytes, Cytotoxic
- Simian immunodeficiency virus
- Simian Immunodeficiency Virus
- Peptides
- Peptide Fragments
- Neutralization Tests
- Molecular Sequence Data
- Macaca mulatta
- Humans
- Histocompatibility Antigens Class I
Citation
APA
Chicago
ICMJE
MLA
NLM
Haynes, B. F., Yasutomi, Y., Torres, J. V., Gardner, M. B., Langlios, A. J., Bolognesi, D. P., … Moody, M. A. (1993). Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy. Trans Assoc Am Physicians, 106, 33–41.
Haynes, B. F., Y. Yasutomi, J. V. Torres, M. B. Gardner, A. J. Langlios, D. P. Bolognesi, T. J. Matthews, R. M. Scearce, D. M. Jones, and M. A. Moody. “Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.” Trans Assoc Am Physicians 106 (1993): 33–41.
Haynes BF, Yasutomi Y, Torres JV, Gardner MB, Langlios AJ, Bolognesi DP, et al. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy. Trans Assoc Am Physicians. 1993;106:33–41.
Haynes, B. F., et al. “Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.” Trans Assoc Am Physicians, vol. 106, 1993, pp. 33–41.
Haynes BF, Yasutomi Y, Torres JV, Gardner MB, Langlios AJ, Bolognesi DP, Matthews TJ, Scearce RM, Jones DM, Moody MA. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy. Trans Assoc Am Physicians. 1993;106:33–41.
Published In
Trans Assoc Am Physicians
ISSN
0066-9458
Publication Date
1993
Volume
106
Start / End Page
33 / 41
Location
United States
Related Subject Headings
- T-Lymphocytes, Cytotoxic
- Simian immunodeficiency virus
- Simian Immunodeficiency Virus
- Peptides
- Peptide Fragments
- Neutralization Tests
- Molecular Sequence Data
- Macaca mulatta
- Humans
- Histocompatibility Antigens Class I